What is the next step in management for a patient with a persistently elevated white blood cell count after completing cellulitis therapy?

Persistently Elevated WBC After Cellulitis Treatment

Reassess the patient clinically for treatment failure, alternative diagnoses, or underlying conditions—if the cellulitis has clinically improved despite persistent leukocytosis, no additional antibiotics or investigations are typically needed.

Clinical Assessment Framework

The key distinction is whether the skin infection itself has improved versus the laboratory value alone. Leukocytosis commonly persists after clinical improvement and does not by itself indicate treatment failure 1.

Evaluate for Treatment Failure

Look specifically for:

• Worsening or non-improving erythema, warmth, swelling, or pain at the infection site
• Persistent or new fever (>38.5°C)
• Systemic signs: tachycardia (>110 bpm), hypotension, confusion
• Spreading margins of erythema despite 48-72 hours of appropriate antibiotics

If these are present, consider:

1. MRSA coverage if not already provided—particularly if there's purulent drainage, penetrating trauma, injection drug use, or nasal MRSA colonization 1
2. Deeper infection: Obtain imaging (ultrasound or CT) to exclude abscess, necrotizing fasciitis, or osteomyelitis
3. Blood cultures if systemic toxicity is present 1

If Cellulitis Has Clinically Improved

Do not extend antibiotics based solely on elevated WBC. The guidelines are clear: 5 days of antibiotics is sufficient for uncomplicated cellulitis if clinical improvement has occurred 1.

Persistent leukocytosis after clinical improvement may reflect:

• Normal inflammatory resolution: WBC can remain elevated for days to weeks after tissue damage resolves 2
• Stress response: Surgery, trauma, emotional stress can double WBC within hours 3
• Underlying conditions: Obesity, smoking, chronic inflammatory states 3

Alternative Diagnoses to Consider

If the "cellulitis" is not improving, reconsider the diagnosis entirely:

• Venous stasis dermatitis (often bilateral, chronic changes)
• Deep venous thrombosis
• Contact dermatitis or other inflammatory dermatoses
• Note: Bilateral cellulitis is rare 4

When to Investigate Further

Obtain blood cultures and consider tissue biopsy/aspirate only if 1:

• Malignancy or chemotherapy
• Neutropenia or severe immunodeficiency
• Unusual exposures (immersion injury, animal bites)
• High fever with hypotension
• Failure to improve after 5 days of appropriate antibiotics

Common Pitfalls

Avoid reflexive antibiotic extension for isolated leukocytosis. Studies show that prolonged broad-spectrum antibiotics in patients with persistent leukocytosis without active infection lead to:

• Colonization with resistant organisms (including C. difficile)
• No improvement in WBC or clinical outcomes
• Prolonged hospitalization 2

The inflammatory response can paradoxically worsen initially after starting antibiotics due to bacterial lysis releasing inflammatory enzymes—this is expected and does not indicate treatment failure 1.

Management Algorithm

1. Day 5 of antibiotics: Assess clinical improvement (reduced erythema, pain, warmth)

   • Improved: Stop antibiotics regardless of WBC 1
   • Not improved: Extend therapy, consider MRSA coverage, image for complications

2. Persistent WBC >11K after clinical cure: No action needed unless:

   • New symptoms develop
   • WBC continues rising (not plateauing/declining)
   • Duration >2-3 weeks with progressive elevation

3. If WBC remains elevated >3 weeks post-cure: Consider hematology referral to exclude primary bone marrow disorder 5, 3